Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Fetomaternal Microchimerism Is Associated with Better Outcome in Haploidentical Hematopoietic Stem Cell Transplantation

Anne Kruchen, PhD, Tanja Stahl, Friederike Gieseke, PhD, Thomas MC Binder, MD, Zakir Oezcan, PhD, Roland Meisel, MD, Hermann Kreyenberg, PhD, Peter Bader, Bernd Gruhn, MD, Johann Greil, MD, Matthias Pfeiffer, MD, Michaela Doering, MD, Rupert Handgretinger, Boris Fehse, Prof, Ingo Mueller, MD

Blood (2014) 124 (21): 1242.

https://doi.org/10.1182/blood.V124.21.1242.1242

Published: 2014

Journal Articles

Monitoring of Minimal Residual Disease After Allogeneic Stem Cell Transplantation In Relapsed Childhood ALL Allows The Identification Of Impending Relapse - Results Of The ALL BFM SCT 2003 Trial

Peter Bader, Hermann Kreyenberg, PhD, Arend von Stackelberg, Cornelia Eckert, PhD, Meisel Roland, MD, Pötschger Ulrike, MD, Daniel Stachel, MD, Martin Schrappe, MD, Andre Schrauder, MD, Ansgar Schulz, MD, Peter Lang, MD, Ingo Mueller, MD, Michael H. Albert, MD, Thomas Klingebiel, MD, Christina Peters, MD

Blood (2013) 122 (21): 1995.

https://doi.org/10.1182/blood.V122.21.1995.1995

Published: 2013

Journal Articles

Alternative Donor Stem Cell Transplantation In Aplastic Anemias and Refractory Cytopenias Is Save and Feasible With T- and B-Cell Depleted Haploidentical Grafts

Tobias Feuchtinger, MD, Heiko-Manuel Teltschik, MD, Matthias Pfeiffer, Ingo Mueller, Andre Schrauder, MD, Rupert Handgretinger, Peter Lang, MD

Blood (2013) 122 (21): 4573.

https://doi.org/10.1182/blood.V122.21.4573.4573

Published: 2013

Journal Articles

Impact Of Prophylaxis With Defibrotide On The Occurrence Of Acute GvHD In Allogeneic HSCT

Blood (2013) 122 (21): 4591.

https://doi.org/10.1182/blood.V122.21.4591.4591

Published: 2013

Journal Articles

Use of IL15 Stimulated, CD3/19 Depleted Transplants From Haploidentical Donors In Pediatric Malignancies

Peter Lang, Matthias Pfeiffer, Heiko-Manuel Teltschik, Tobias F. Feuchtinger, MD, Martin Ebinger, Ingo Mueller, Michael Schumm, Rupert Handgretinger, MD, PhD

Blood (2010) 116 (21): 3548.

https://doi.org/10.1182/blood.V116.21.3548.3548

Published: 2010

Journal Articles

Defibrotide (DF) for the Prevention of Hepatic Veno-Occlusive Disease (VOD) in Pediatric Stem Cell Transplantion: Results of a Prospective Phase II/III Randomized, Multicenter Study.

Blood (2009) 114 (22): 653.

https://doi.org/10.1182/blood.V114.22.653.653

Published: 2009

Journal Articles

Improved T Cell Recovery After Transplantation of CD3/CD19 depleted Haploidentical Stem Cell Grafts in Pediatric Patients.

Heiko-Manuel Teltschik, Tobias Feuchtinger, Matthias Pfeiffer, Michael Schumm, Ingo Mueller, Rupert Handgretinger, Peter J. Lang, MD

Blood (2009) 114 (22): 4652.

https://doi.org/10.1182/blood.V114.22.4652.4652

Published: 2009

Journal Articles

Incidence of Veno-Occlusive Disease with IV in Busulfan Children Is Higher Than Expected: Preliminary Results of the VOD-DF Trial.

Blood (2009) 114 (22): 3344.

https://doi.org/10.1182/blood.V114.22.3344.3344

Published: 2009

Journal Articles

Long Term Survival and Relapse Rate After Transplantation of Highly T and B Cell Depleted Stem Cells From Alternative Donors in Pediatric Patients with Acute Lymphatic Leukemia.

Peter J. Lang, MD, Ingo Mueller, Heiko-Manuel Teltschik, Michael Schumm, Matthias Pfeiffer, Tobias Feuchtinger, Johann Greil, Peter Bader, Thomas Klingebiel, MD, Rupert Handgretinger, MD

Blood (2009) 114 (22): 4333.

https://doi.org/10.1182/blood.V114.22.4333.4333

Published: 2009

Journal Articles

Co-Transfusion of Donor NK Cells in Haploidentical Stem Cell Transplantation

Peter J. Lang, MD, Matthias Pfeiffer, MD, Heiko-Manuel Teltschik, MD, Ingo Mueller, MD, Tobias Feuchtinger, MD, Michael Schumm, MD, Rupert Handgretinger, MD

Blood (2008) 112 (11): 2907.

https://doi.org/10.1182/blood.V112.11.2907.2907

Published: 2008

Journal Articles

A New Conditioning Regimen with Clofarabine for Allogeneic Stem Cell Transplantation in Pediatric Patients with Refractory Disease.

Peter J. Lang, MD, Ingo Mueller, MD, Heiko Teltschik, MD, Matthias Pfeiffer, MD, Martin Ebinger, MD, Tobias Feuchtinger, MD, Rupert Handgretinger, MD

Blood (2007) 110 (11): 3019.

https://doi.org/10.1182/blood.V110.11.3019.3019

Published: 2007

Journal Articles

Low Transplant Related Toxicity and Mortality after Transplantation of CD3/CD19 Depleted Haploidentical Stem Cells with Reduced Intensity Conditioning in Children.

Peter J. Lang, MD, Ingo Mueller, MD, Heiko Teltschik, MD, Matthias Pfeiffer, MD, Martin Ebinger, MD, Michael Schumm, MD, Rupert Handgretinger, MD

Blood (2007) 110 (11): 3076.

https://doi.org/10.1182/blood.V110.11.3076.3076

Published: 2007

Journal Articles

CD3/CD19 Depleted Grafts for Haploidentical Stem Cell Transplantation in Children: Results of a Pilot Study.

Peter J. Lang, MD, Ingo Mueller, MD, Johann Greill, MD, Peter Bader, MD, Michael Schumm, Dr. med. vet., Matthias Pfeiffer, MD, Tobias Feuchtinger, MD, Rupert Handgretinger, MD

Blood (2006) 108 (11): 3121.

https://doi.org/10.1182/blood.V108.11.3121.3121

Published: 2006

Journal Articles

Isolation and Expansion of Functional Differentiating Mesenchymal Stem Cells with a Serum Deprived Medium.

Massimo Dominici, MD, Ingo Mueller, MD, PhD, Luigi Cafarelli, MS, Sandra Kordowich, MD, Rita Sternieri, MD, Carlotta Spano, MS, Caterina Chiodino, MD, PhD, Ilaria Mariotti, MD, Istvan Petak, MD, PhD, Edwin Horwitz, MD, PhD, Paolo Paolucci, MD, Pierfranco Conte, MD

Blood (2004) 104 (11): 2852.

https://doi.org/10.1182/blood.V104.11.2852.2852

Published: 2004

NARROW

Fetomaternal Microchimerism Is Associated with Better Outcome in Haploidentical Hematopoietic Stem Cell Transplantation

Monitoring of Minimal Residual Disease After Allogeneic Stem Cell Transplantation In Relapsed Childhood ALL Allows The Identification Of Impending Relapse - Results Of The ALL BFM SCT 2003 Trial

Alternative Donor Stem Cell Transplantation In Aplastic Anemias and Refractory Cytopenias Is Save and Feasible With T- and B-Cell Depleted Haploidentical Grafts

Impact Of Prophylaxis With Defibrotide On The Occurrence Of Acute GvHD In Allogeneic HSCT

Use of IL15 Stimulated, CD3/19 Depleted Transplants From Haploidentical Donors In Pediatric Malignancies

Defibrotide (DF) for the Prevention of Hepatic Veno-Occlusive Disease (VOD) in Pediatric Stem Cell Transplantion: Results of a Prospective Phase II/III Randomized, Multicenter Study.

Improved T Cell Recovery After Transplantation of CD3/CD19 depleted Haploidentical Stem Cell Grafts in Pediatric Patients.

Incidence of Veno-Occlusive Disease with IV in Busulfan Children Is Higher Than Expected: Preliminary Results of the VOD-DF Trial.

Long Term Survival and Relapse Rate After Transplantation of Highly T and B Cell Depleted Stem Cells From Alternative Donors in Pediatric Patients with Acute Lymphatic Leukemia.

Co-Transfusion of Donor NK Cells in Haploidentical Stem Cell Transplantation

A New Conditioning Regimen with Clofarabine for Allogeneic Stem Cell Transplantation in Pediatric Patients with Refractory Disease.

Low Transplant Related Toxicity and Mortality after Transplantation of CD3/CD19 Depleted Haploidentical Stem Cells with Reduced Intensity Conditioning in Children.

CD3/CD19 Depleted Grafts for Haploidentical Stem Cell Transplantation in Children: Results of a Pilot Study.

Isolation and Expansion of Functional Differentiating Mesenchymal Stem Cells with a Serum Deprived Medium.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only